BA
Brian Atwood
OtherActiveManaging Director at Versant Ventures
67
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Brian Atwood.
Investment Thesis & Strategy
Brian Atwood, as a Managing Director at Versant Ventures, invests in various stages of AI/ML, Analytics, Consumer Internet, Enterprise, and Media/Content companies. Versant Ventures typically seeks to invest in companies with innovative technologies and strong market potential.
Portfolio Companies
Selected investments from their portfolio of 67 companies
M
Monte Rosa Therapeutics
Biotech · Series A, 0
L
Lava Therapeutics
Other · , 0
R
ROX Medical
Other · , 0
A
AcuFocus
Other · , 0
A
Anokion
Other · , 0
I
Ivantis
Other · , 0
L
Laguna Pharmaceuticals
Other · , 0
R
RayzeBio
Biotech · Series A, 0
B
BlueRock Therapeutics
Biotech · Series A, 0
S
Sebacia
Biotech · Series A, 0
R
Repare Therapeutics
Biotech · Series A, 0
Q
Quentis Therapeutics
Biotech · Series A, 0
Frequently Asked Questions
Brian Atwood focuses on Seed stage investments.